An underground economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.
Investigational Drug Acquiring Traction Online
Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Viewers are urged to message these profiles directly for supplier links, while also receiving discount codes.
Thriving Trade on Social Networks
Additionally, a flourishing market exists on Telegram, where communities with numerous of members share “before and after” images, administration instructions and claims of next-day UK delivery. Vendors market the substance there before redirecting buyers to WhatsApp for transactions.
Learning About Retatrutide
Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.
Healthcare Professionals Voice Concerns
However, doctors and chemists have warned that the sale of what is still an unapproved medication in the UK is a cause for concern and could lead to individuals administering substances of unknown origin.
Several experts said the popularity for retatrutide could be connected to the increasing price of licensed slimming products such as Mounjaro.
Regulatory Status and Implementation
Marketing the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that must not be marketed or distributed for human use under the British medical regulations.
Several influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate pharmaceutical, marketing, and customer regulations, potentially leading to fines, legal action or imprisonment.
Service Reaction and Content Removal
Based on the social media company, the service has removed problematic material and banned related hashtags and search suggestions. The company stated it was dedicated to maintaining the service secure and investing in strengthening compliance measures.
Online Marketplace Activities
Research also discovered communities with up to 9,000 participants marketing retatrutide using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” immediately brings up channels with thousands of members, filled with photos of slimming results, glowing testimonials and detailed instructions for preparing or administering at residence.
After moments of entering one group, a seller posted WhatsApp details, where the majority of transactions take place. The seller sent an instruction manual and promised delivery within two days. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one asked about weight, medical conditions or previous experience.
Product Information and Pricing
Inside these communities, posts show dark colored parcels with Royal Mail stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at residence with purified liquid, or pre-filled pens usually sold at £160 for 20mg. When asked how long a pen should be used, sellers give conflicting answers varying between a several days to “depends on your body”.
Platform Moderation and Security Actions
A spokesperson for the messaging service stated it regularly moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are injecting substances they can’t verify. Although the science behind this drug is valid, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor linked the increase in interest to current price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit injections are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.
Her staff has previously encountered patients harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may subject patients to potentially significant medical dangers”.
